Michael Leverentz

Michael Leverentz is an innovative life sciences professional with a strong technical background, who has worked in academic, industrial, and healthcare sectors. He has a proven track record in developing and maintaining collaborations, managing senior stakeholders, and coordinating diverse project partners in commercial and academic biomedical research.

He possesses strong analytical and problem-solving skills, excels in communicating to both technical and non-technical audiences, and has a broad scientific experience with a focus on stem/progenitor cell and cancer biology, as well as USP biologic production.

Michael Leverentz holds a Ph.D. in Biochemistry from Royal Holloway, University of London, and a B.A. in Botany/Plant Sciences and English Literature from the University of California, Riverside.

His professional journey includes roles such as Research Resource Strategist at Mechanobiology Institute, Member of the Scientific Advisory Board at Affinity Biomarker Labs, Research Strategy Coordinator at The University of Manchester, Institute Manager at The University of Manchester - Manchester Institute of Collaborative Research on Ageing, and Project Manager at Manchester Regenerative Medicine Network at The University of Manchester.

He has also served as a Post Doctoral Research Associate and Lab Manager, Molecular Biology Team Leader and Scientist at various esteemed organizations like Oxyrane U.K. Ltd, University of Manchester, and Paterson Institute for Cancer Research.